| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc. (ARCT) has 5 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. ARCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 221.8K | $1.67M | - | |
| CEO | 175.0K | $1.32M | - | |
| COO | 54.0K | $406.6K | - | |
| Other | 54.0K | $406.6K | - | |
| Other | 10.0K | $75.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $54.23 | $542,300.00 | -1.5% | -45.2% | -59.6% | |
| Feb 1, 2021 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $75.31 | $753,100.00 | -1.5% | - | - | |
| Jan 4, 2021 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $46.40 | $464,000.00 | -1.4% | - | - | |
| Dec 1, 2020 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $96.19 | $961,900.00 | -1.4% | - | - | |
| Nov 2, 2020 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $55.28 | $552,800.00 | -1.4% | - | - | |
| Oct 1, 2020 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $42.83 | $428,300.00 | -1.4% | - | - | |
| Sep 3, 2020 | Chivukula Pad78 | Chief Scientific Officer &COO | Sell | 10,000 | $45.16 | $451,600.00 | -1.4% | - | - | |
| Jun 12, 2020 | Kummerfeld Keith C | See Remarks | Buy | 450 | $33.33 | $14,998.50 | +90.0% | - | - | |
| Jun 10, 2020 | Payne Joseph E | President And CEO | Buy | 1,000 | $31.69 | $31,690.00 | - | - | - | |
| Jun 10, 2020 | Sassine Andy | Chief Financial Officer | Buy | 5,000 | $29.74 | $148,700.00 | +1.9% | - | - |